Lv5
1170 积分 2024-11-08 加入
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial
5个月前
已完结
Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resection
5个月前
已完结
Gadoxetic Acid–enhanced MRI Scoring Model to Predict Pathologic Features of Hepatocellular Carcinoma
5个月前
已完结
Quantitative analysis of enhanced CT in predicting microvascular invasion and pathological grading of hepatocellular carcinoma
5个月前
已完结
Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma
5个月前
已完结
Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma
6个月前
已完结
Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma
6个月前
已完结
The Difficult Cholecystectomy
6个月前
已完结
Clinical practice and implications of biomarker testing in biliary tract cancer: an observational study☆
8个月前
已完结
An etiology-stratified single-cell atlas identifies FABP4 as a prognostic marker for MASLD-related HCC
8个月前
已完结
皖公网安备34019202002308
